Veru Inc (VERU)
0.8133
-0.03
(-3.01%)
USD |
NASDAQ |
Jun 14, 16:00
0.8102
0.00 (0.00%)
After-Hours: 20:00
Veru Profit Margin (Quarterly): -242.4% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -242.4% |
December 31, 2023 | -386.6% |
September 30, 2023 | -281.1% |
June 30, 2023 | -199.3% |
March 31, 2023 | -513.0% |
December 31, 2022 | -1.54K% |
September 30, 2022 | -1.59K% |
June 30, 2022 | -231.2% |
March 31, 2022 | -108.8% |
December 31, 2021 | -45.14% |
September 30, 2021 | -27.45% |
June 30, 2021 | -15.25% |
March 31, 2021 | -21.33% |
December 31, 2020 | |
September 30, 2020 | -100.7% |
June 30, 2020 | -29.31% |
March 31, 2020 | -8.15% |
December 31, 2019 | -31.24% |
September 30, 2019 | -35.06% |
June 30, 2019 | -28.52% |
March 31, 2019 | -57.83% |
December 31, 2018 | -33.72% |
September 30, 2018 | -152.2% |
June 30, 2018 | -144.1% |
March 31, 2018 | -148.9% |
Date | Value |
---|---|
December 31, 2017 | -164.6% |
September 30, 2017 | -72.56% |
June 30, 2017 | -18.31% |
March 31, 2017 | -73.86% |
December 31, 2016 | -42.12% |
September 30, 2016 | -49.14% |
June 30, 2016 | 10.26% |
March 31, 2016 | 0.73% |
December 31, 2015 | 18.11% |
September 30, 2015 | 9.82% |
June 30, 2015 | 14.99% |
March 31, 2015 | 15.19% |
December 31, 2014 | 12.09% |
September 30, 2014 | -10.19% |
June 30, 2014 | 14.68% |
March 31, 2014 | 8.63% |
December 31, 2013 | 21.89% |
September 30, 2013 | |
June 30, 2013 | 9.98% |
March 31, 2013 | 36.84% |
December 31, 2012 | 35.66% |
September 30, 2012 | 82.58% |
June 30, 2012 | 29.46% |
March 31, 2012 | 24.32% |
December 31, 2011 | 30.81% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.59K%
Minimum
Sep 2022
-8.15%
Maximum
Mar 2020
-286.5%
Average
-100.7%
Median
Sep 2020
Profit Margin (Quarterly) Benchmarks
EyePoint Pharmaceuticals Inc | -250.6% |
INVO Bioscience Inc | -101.3% |
Bio-Path Holdings Inc | -- |
Aileron Therapeutics Inc | -- |
ProKidney Corp | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -106.9% |
Return on Assets | -51.49% |
Return on Invested Capital | -81.89% |
Gross Profit Margin (Quarterly) | 16.40% |
Operating Margin (Quarterly) | -239.1% |
Return on Net Operating Assets | -129.4% |